89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ETNB 89Bio, Inc.

盘前交易 05-03 04:20:20 EDT

8.86

+0.11

+1.26%

最高9.15	最低8.56	成交量58.84万
今开8.87	昨收8.75	日振幅6.74%
总市值8.44亿	流通市值6.19亿	总股本9,522万
成交额522.11万	换手率0.84%	流通股本6,982万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ETNB","market":"US","secType":"STK","nameCN":"89Bio, Inc.","latestPrice":8.86,"timestamp":1714680000000,"preClose":8.75,"halted":0,"volume":588356,"delay":0,"floatShares":69817396,"shares":95224724,"eps":-1.997797,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.11,"latestTime":"05-03 04:20:20 EDT","open":8.87,"high":9.15,"low":8.56,"amount":5221119.389192,"amplitude":0.067429,"askPrice":9.5,"askSize":3,"bidPrice":3.55,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.997797,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714743000000},"adr":0,"listingDate":1573448400000,"adjPreClose":8.86,"postHourTrading":{"tag":"盘后","latestPrice":8.86,"preClose":8.86,"latestTime":"16:09 EDT","volume":25938,"amount":229823.28,"timestamp":1714680548117},"volumeRatio":0.7784136268956163},"requestUrl":"/m/hq/s/ETNB/","defaultTab":"news","newsList":[{"id":"2426494343","title":"89Bio, Inc.盘中异动 大幅下跌5.14%报10.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494343","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426494343?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:30","pubTimestamp":1712755858,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时30分，89Bio, Inc.股票出现异动，股价快速下挫5.14%。截至发稿，该股报10.34美元/股，成交量9387股，换手率0.01%，振幅0.28%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102130587a51e7b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102130587a51e7b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419124937","title":"资料盒-Madrigal公司的药物在美国首次获批治疗脂肪肝NASH，竞争对手却围追堵截","url":"https://stock-news.laohu8.com/highlight/detail?id=2419124937","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419124937?lang=zh_cn&edition=full","pubTime":"2024-03-15 04:09","pubTimestamp":1710446976,"startTime":"0","endTime":"0","summary":"    路透社3月14日 - Madrigal Pharmaceuticals公司的  药物成为第一个获得监管部门批准的 ，用于治疗一种以前被称为非酒精性脂肪性肝炎的严重类型的脂肪肝，因为开发一个数十亿美元市场的竞争正在加剧。在周四获得批准之前，该公司在开发这种疾病的治疗方法方面取得了有限的成功，这种疾病与肥胖密切相关，而且正在迅速蔓延。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409784452","title":"89Bio Inc盘中异动 早盘股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409784452","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409784452?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:57","pubTimestamp":1707317838,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日22时57分，89Bio Inc股票出现波动，股价大幅拉升5.29%。截至发稿，该股报8.56美元/股，成交量20.1285万股，换手率0.22%，振幅4.80%。89Bio Inc股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Oculis Holding Ag C/Wts 06/03/2028 、Invivo Therapeutics Holding Corp涨幅较大，Invivo Therapeutics Holding Corp、Biodexa Pharmaceuticals Plc、Altamira Therapeutics Ltd较为活跃，换手率分别为412.74%、262.44%、45.78%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Invivo Therapeutics Holding Corp，振幅分别为103.54%、80.75%、45.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402072257187910119e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402072257187910119e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409683285","title":"BUZZ-礼来公司的减肥药在试验中显示出前景，NASH 药物开发商业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2409683285","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409683285?lang=zh_cn&edition=full","pubTime":"2024-02-07 00:42","pubTimestamp":1707237750,"startTime":"0","endTime":"0","summary":" (更新)    2月6日 - ** 礼来公司的  减肥药 达到了脂肪肝患者中期试验的主要目标，导致开发NASH治疗药物的公司股价下跌 ** 礼来公司周二在 ，称替泽帕肽帮助73.9%的患者在52周时实现了 \"不发病 \"的目标** 非酒精性脂肪性肝炎 是脂肪肝的一种类型，目前市场上还没有批准的治疗方法。** 竞争对手Akero Therapeutics   的股价跌 至近两个月低点 15.32美元**NeuroBo Pharmaceuticals   和89bio Inc   等其他NASH药物开发商的股价分别下跌12.4%至4.38美元和23.8%至7.47美元的两个多月低点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409403983","title":"BUZZ-礼来公司的药物在试验中显示出前景，NASH 药物开发商纷纷倒下","url":"https://stock-news.laohu8.com/highlight/detail?id=2409403983","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409403983?lang=zh_cn&edition=full","pubTime":"2024-02-06 21:38","pubTimestamp":1707226735,"startTime":"0","endTime":"0","summary":"    2月6日 - ** 在礼来公司的  减肥药达到了脂肪肝患者中期试验的主要目标后，开发治疗NASH药物的公司股价在上市前下跌 ** 礼来公司周二在 ，称替泽帕肽帮助多达73.9%的患者实现了 \"不发病\"，52周时肝脏瘢痕没有恶化。** 89bio Inc   等其他NASH药物开发商的股价下跌10.7%，NeuroBo Pharmaceuticals   下跌3.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407399868","title":"89Bio Inc盘中异动 急速下挫5.04%报10.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407399868","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407399868?lang=zh_cn&edition=full","pubTime":"2024-01-31 02:37","pubTimestamp":1706639850,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日02时37分，89Bio Inc股票出现波动，股价急速下跌5.04%。截至发稿，该股报10.17美元/股，成交量23.487万股，换手率0.25%，振幅5.04%。89Bio Inc股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Neximmune Inc、Pepgen Inc、Gri Bio Inc涨幅较大，Neximmune Inc、Panbela Therapeutics Inc、Gri Bio Inc较为活跃，换手率分别为1512.30%、283.68%、250.66%，振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Gri Bio Inc，振幅分别为800.00%、218.65%、89.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131023731790d7fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131023731790d7fba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2403226787","title":"BUZZ--美国股票走势-Polestar Automotive、Momentus、石油公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2403226787","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2403226787?lang=zh_cn&edition=full","pubTime":"2024-01-13 00:14","pubTimestamp":1705076093,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      早间新闻电话通讯：      1月12日 - 华尔街主要股指周五攀升，原因是通胀报告低于预期，提振了提前开始降息的希望，同时投资者对主要贷款机构的财报进行了评估，结果喜忧参半。美东时间10:40，道琼斯工业平均指数  下跌0.46%，报37536.16美元。标普500指数  下跌0.05%，报4777.82点；纳斯达克综合指数  上涨0.05%，报14978.29点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402242181","title":"89Bio Inc盘中异动 早盘急速下跌6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402242181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402242181?lang=zh_cn&edition=full","pubTime":"2024-01-12 22:31","pubTimestamp":1705069893,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日22时31分，89Bio Inc股票出现波动，股价快速下跌6.09%。截至发稿，该股报10.49美元/股，成交量8.7879万股，换手率0.09%，振幅2.60%。89Bio Inc股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Calcimedica Inc、Atreca Inc涨幅较大，Jaguar Health Inc、Atreca Inc、Clearmind Medicine Inc较为活跃，换手率分别为41.91%、36.86%、7.15%，振幅较大的相关个股有Atreca Inc、Neximmune Inc、Conduit Pharmaceuticals Inc，振幅分别为8.44%、6.93%、6.70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011222313387b40bdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011222313387b40bdd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402429652","title":"BUZZ--美国股票走势-医疗保险公司、贝莱德、铀矿商","url":"https://stock-news.laohu8.com/highlight/detail?id=2402429652","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402429652?lang=zh_cn&edition=full","pubTime":"2024-01-12 22:26","pubTimestamp":1705069577,"startTime":"0","endTime":"0","summary":"美东时间9:02，道指电子盘  下跌0.27%，报37823点。标普500指数小型股  下跌0.02%，报收于4,814.75点；纳斯达克100指数小型股  下跌0.02%，报收于16,963.25点。** 铀能源   ：盘前上涨 5.1** Ur-Energy   ：盘前上涨 4.3** Cameco   ：盘前上涨5.5%BUZZ - Kazatomprom标明2024年产量不足后，铀矿商跳涨   ** Momentus   ：盘前下跌 40.0%BUZZ - 因太空技术公司标明持续经营存疑而下滑   ** CF Industries Holdings   ：盘前上涨1%BUZZ - 因巴克莱将其评级上调至 \"等权重 \"而上涨   ** Snowflake   ：盘前下跌2.1%BUZZ - 巴克莱因竞争逆风下调其评级而下跌","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402245404","title":"BUZZ-由于加拿大皇家银行将 89bio 的评级下调至 \"行业表现\"，并下调 PT，该公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2402245404","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402245404?lang=zh_cn&edition=full","pubTime":"2024-01-12 20:57","pubTimestamp":1705064263,"startTime":"0","endTime":"0","summary":"    1月12日 - ** 药物开发商 89bio    股价盘前下跌 ~4% 至 10.73 美元 ** 经纪公司 RBC Capital 将股票评级从 \"跑赢大盘 \"下调至 \"行业表现\"，并将目标价从 24 美元下调至 15 美元。** 券商预计该公司的实验性脂肪肝药物pegozafermin的试验结果较少** ETNB 将在今年启动多项  后期研究，测试该药物治疗代谢功能障碍相关性脂肪性肝炎，也称为非酒精性脂肪性肝炎。** 2023 年股价下跌 12.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.89bio.com","stockEarnings":[{"period":"1week","weight":0.0739},{"period":"1month","weight":-0.1626},{"period":"3month","weight":-0.1082},{"period":"6month","weight":0.0535},{"period":"1year","weight":-0.4614},{"period":"ytd","weight":-0.2068}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0266},{"period":"3month","weight":0.0216},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.2378},{"period":"ytd","weight":0.0625}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"89bio, Inc.于2019年6月作为一家特拉华州公司成立，以经营2018年1月在以色列注册成立的89Bio有限公司的业务。该公司是一家临床阶段的生物制药公司，致力于开发治疗肝脏和心血管疾病的创新疗法并将其商业化。他们的主要候选产品BIO89-100是FGF21的经过特殊工程改造的糖聚乙二醇化类似物，目前正在开发中，用于治疗NASH。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.179236},{"month":2,"riseRate":0.8,"avgChangeRate":0.131113},{"month":3,"riseRate":0.4,"avgChangeRate":-0.076134},{"month":4,"riseRate":0.4,"avgChangeRate":-0.12055},{"month":5,"riseRate":0.8,"avgChangeRate":0.076727},{"month":6,"riseRate":0.5,"avgChangeRate":-0.03191},{"month":7,"riseRate":0.5,"avgChangeRate":0.075034},{"month":8,"riseRate":1,"avgChangeRate":0.19692},{"month":9,"riseRate":0.5,"avgChangeRate":-0.019034},{"month":10,"riseRate":0.25,"avgChangeRate":-0.017585},{"month":11,"riseRate":0.5,"avgChangeRate":-0.039754},{"month":12,"riseRate":0.4,"avgChangeRate":0.142591}],"exchange":"NASDAQ","name":"89Bio, Inc.","nameEN":"89Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"89Bio, Inc.,ETNB,89Bio, Inc.股票,89Bio, Inc.股票老虎,89Bio, Inc.股票老虎国际,89Bio, Inc.行情,89Bio, Inc.股票行情,89Bio, Inc.股价,89Bio, Inc.股市,89Bio, Inc.股票价格,89Bio, Inc.股票交易,89Bio, Inc.股票购买,89Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}